Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to -$4.8 million.

  • Harmony Biosciences Holdings' Cash from Investing Activities fell 742.82% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 69.69%. This contributed to the annual value of -$67.5 million for FY2024, which is 45.32% down from last year.
  • Harmony Biosciences Holdings' Cash from Investing Activities amounted to -$4.8 million in Q3 2025, which was up 75.55% from -$19.6 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Cash from Investing Activities registered a high of $2.4 million during Q1 2025, and its lowest value of -$100.0 million during Q1 2021.
  • Its 3-year average for Cash from Investing Activities is -$12.4 million, with a median of -$6.2 million in 2024.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Cash from Investing Activities tumbled by 34,787.10% in 2022 and then soared by 191.64% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Cash from Investing Activities (Quarterly) stood at -$93,000 in 2021, then crashed by 34,787.10% to -$46.9 million in 2022, then climbed by 23.09% to -$36.1 million in 2023, then spiked by 80.07% to -$7.2 million in 2024, then crashed by 742.82% to -$4.8 million in 2025.
  • Its Cash from Investing Activities was -$4.8 million in Q3 2025, compared to -$19.6 million in Q2 2025 and $2.4 million in Q1 2025.